Header

UZH-Logo

Maintenance Infos

Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen - Zurich Open Repository and Archive


Weisberg, E; Merki-Feld, G S; McGeechan, K; Fraser, I S (2015). Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen. Contraception, 91(2):121-126.

Abstract

OBJECTIVES: To compare bleeding patterns for 12months continuous use of a contraceptive ring [contraceptive vaginal ring (CVR)] and pill [combined oral contraceptive (COC)] on a menstrually signaled regimen and the effectiveness of 4days "treatment withdrawal" to stop bleeding.
STUDY DESIGN: Women, 66 to each group, were randomized to continuous use of a CVR (15mcg ethinyl estradiol/150mcg etonogestrel) or a low-dose pill (20mcg ethinyl estradiol/100mcg levonorgestrel) for 360days on a menstrually signaled regimen. Bleeding/spotting days, daily use of ring or pill, was recorded. Endpoint was the total number of bleeding/spotting days for each method over four 90-day reference periods (RP) plus the analysis of bleeding patterns using modified World Health Organization criteria.
RESULTS: There was a reduction in the mean (±S.D.) number of bleeding/spotting days from RP1 (CVR 14.2±10; pill 16.6±10.9) to RP4 (CVR 8.8±9.6; pill 8.8±9.1). Fifteen percent of CVR and 4% COC users experienced amenorrhea or infrequent bleeding throughout the study. Amenorrhea increased over time (RP1 vs. RP4: CVR 10% vs. 21% and COC 2% vs. 30%). Compliance with the menstrually signaled regimen was poor. Ceasing hormones for 4days stopped a bleeding episode within 5days in the majority of episodes and many stopped spontaneously.
CONCLUSION: Bleeding patterns with continuous use of the CVR and COC are similar and improve over 1year of use. The unpredictability, but short duration, of bleeding episodes should be stressed during counseling.
IMPLICATION: This information for clinicians and women about breakthrough bleeding patterns with use of a CVR or combined pill over 12months using a menstrually signaled regimen will give women an indication of what to expect with continuous use.

Abstract

OBJECTIVES: To compare bleeding patterns for 12months continuous use of a contraceptive ring [contraceptive vaginal ring (CVR)] and pill [combined oral contraceptive (COC)] on a menstrually signaled regimen and the effectiveness of 4days "treatment withdrawal" to stop bleeding.
STUDY DESIGN: Women, 66 to each group, were randomized to continuous use of a CVR (15mcg ethinyl estradiol/150mcg etonogestrel) or a low-dose pill (20mcg ethinyl estradiol/100mcg levonorgestrel) for 360days on a menstrually signaled regimen. Bleeding/spotting days, daily use of ring or pill, was recorded. Endpoint was the total number of bleeding/spotting days for each method over four 90-day reference periods (RP) plus the analysis of bleeding patterns using modified World Health Organization criteria.
RESULTS: There was a reduction in the mean (±S.D.) number of bleeding/spotting days from RP1 (CVR 14.2±10; pill 16.6±10.9) to RP4 (CVR 8.8±9.6; pill 8.8±9.1). Fifteen percent of CVR and 4% COC users experienced amenorrhea or infrequent bleeding throughout the study. Amenorrhea increased over time (RP1 vs. RP4: CVR 10% vs. 21% and COC 2% vs. 30%). Compliance with the menstrually signaled regimen was poor. Ceasing hormones for 4days stopped a bleeding episode within 5days in the majority of episodes and many stopped spontaneously.
CONCLUSION: Bleeding patterns with continuous use of the CVR and COC are similar and improve over 1year of use. The unpredictability, but short duration, of bleeding episodes should be stressed during counseling.
IMPLICATION: This information for clinicians and women about breakthrough bleeding patterns with use of a CVR or combined pill over 12months using a menstrually signaled regimen will give women an indication of what to expect with continuous use.

Citations

4 citations in Web of Science®
5 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

20 downloads since deposited on 28 Jan 2015
8 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Reproductive Endocrinology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2015
Deposited On:28 Jan 2015 10:02
Last Modified:05 Apr 2016 18:58
Publisher:Elsevier
ISSN:0010-7824
Publisher DOI:https://doi.org/10.1016/j.contraception.2014.10.006
PubMed ID:25459098

Download

Preview Icon on Download
Preview
Content: Accepted Version
Filetype: PDF
Size: 176kB
View at publisher

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations